Show Summary Details
Page of

Conventional analgesics for bone pain 

Conventional analgesics for bone pain
Conventional analgesics for bone pain

John Zeppetella

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 01 December 2021

Patients with cancer-induced bone pain (CIBP) often report that their pain varies during the course of the day. In general, two types of pain pattern can be identified: a continuous pain (‘background pain’); and a transitory exacerbation of pain (‘breakthrough pain’). This chapter will review the evidence for the effectiveness of conventional analgesics in the management of both background and breakthrough CIBP (i.e. non-opioid analgesics, opioid analgesics). It should be noted that some patients with CIBP may require additional forms of pharmacological intervention to deal with associated muscle spasm (e.g. benzodiazepines), or nerve impingement (e.g. cortico- steroids).

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.